ALYSSA GRUBB: Open Payments
NPI 1588148738 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,534 in 128 payments from 20 companies in 2025. Trend: 2023 $2,067 · 2024 $2,535 · 2025 $2,534
Food & beverage: $2,534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $452 |
| Ardelyx, Inc. | 14 | $445 |
| Janssen Biotech, Inc. | 22 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $214 |
| Gilead Sciences, Inc. | 8 | $195 |
| Madrigal Pharmaceuticals | 7 | $175 |
| QOL Medical, LLC | 4 | $110 |
| VIVUS LLC | 4 | $77 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
Products named: IBSRELA, TREMFYA, XIFAXAN, LINZESS, REZDIFFRA, ENTYVIO, Sucraid, SKYRIZI.
Industry payments across FL — which companies pay providers there.
